Industry-Supported Lunch Symposium (Non-Accredited/Non-Approved for CECH): VERSAJET II in the Outpatient Clinic: Providing Operative Care outside the operating room

Friday, November 2
11:40 AM - 1:10 PM
Location: Milano V-VI

Faculty: Dr Steven Norman, DPM, DABPS

Abstract:
VERSAJET II has been used by surgeons in the operating room with great success and is considered by many to be an invaluable debridement tool. The use of VERSAJET II* in the outpatient setting may offer clinicians and their patients many advantages over more standard outpatient debridement procedures. Over 100 patients have received VERSAJET II debridement in the outpatient wound care center at Wyckoff Heights Medical Center in Brooklyn NY from January 2017 to August of 2017. Over 30 patients have received VERSAJET II debridement in the outpatient wound care center at Flushing Hospital Outpatient Department in Queens, NY from May 2017 to September of 2017.The VERSAJET II was primarily used on chronic wounds such as diabetic foot ulcers, venous ulcers, and pressure ulcers in this outpatient setting. The majority of patients had a single VERSAJET II debridement prior to wound closure, but some patients received two or more VERSAJET II debridements. These patients were selected for VERSAJET debridement based on a number of criteria. These criteria included, but were not limited to, being able to perform a more complete and effective debridement in the outpatient clinic setting as compared with conventional debridement techniques and the patient’s ability to tolerate wound debridement with the VERSAJET II . Using either local, topical, or no anesthesia, the VERSAJET II debridements were performed with excellent results achieving a clean wound bed and were well tolerated by the patients. Performing the procedure was not difficult nor extremely time consuming. The results and experience from the use of VERSAJET II in the clinic was successful and its use is now ongoing as a part of our wound treatment regime. The VERSAJET II was able to be used on patients previously considered as poor operative candidates thereby allowing these high risk patients access to operative care outside of the operating room. The use of the VERSAJET II in the outpatient clinic also allowed for some patients to forgo hospitalization. Other patients had accelerated wound healing due to the effectiveness and precision of the VERSAJET II debridement(s). A more complete and thorough debridement was attainable in the outpatient setting with the use of the VERSAJET◊ II Hydrosurgery System as compared with conventional debridement techniques.

◊ Trademark of Smith & Nephew

*VERSAJET Exact handset configuration 14mm/45 degree angle was used on all patients during this trial. Only VERSAJET Exact 45 degree handsets are suitable for use outside the operating room environment.

Sponsored by Smith & Nephew, Inc.


Assets

Industry-Supported Lunch Symposium (Non-Accredited/Non-Approved for CECH): VERSAJET II in the Outpatient Clinic: Providing Operative Care outside the operating room



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Industry-Supported Lunch Symposium (Non-Accredited/Non-Approved for CECH): VERSAJET II in the Outpatient Clinic: Providing Operative Care outside the operating room